Document is current
Any future updates will be listed below
-
Authors
Zekarias, Alem https://orcid.org/0000-0003-0297-8881
Watson, Sarah https://orcid.org/0000-0001-9660-5968
Vidlin, Sara Hedfors https://orcid.org/0000-0003-1619-3751
Grundmark, Birgitta https://orcid.org/0000-0002-2799-9374
- License Information
-
More Information
Article History
Accepted: 8 September 2020
First Online: 25 September 2020
Declarations
:
: No sources of funding were used to conduct this study or prepare this manuscript.
: Alem Zekarias, Sarah Watson, Sara Hedfors Vidlin, and Birgitta Grundmark have no conflicts of interest that are directly relevant to the content of this study.
: Not applicable.
: Not applicable.
: Not applicable.
: The datasets generated and analysed during the current study are not publicly available because of agreements between contributors of data to the database used (VigiBase) and the custodian of this database. National centres (mainly national drug regulatory authorities) constituting the WHO PIDM contribute data to VigiBase, and the Uppsala Monitoring Centre is the custodian in its capacity as the WHO collaborating centre for international drug monitoring. Some subsets of the data may be available from the corresponding author on reasonable request.
: Code is unavailable.
: All authors contributed to this manuscript.
